Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Peter Corry

Concepts (422)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hyperthermia, Induced
24
2012
115
2.020
 Why?
Heat-Shock Proteins
11
2005
100
1.280
 Why?
Radiotherapy, Intensity-Modulated
10
2017
177
1.160
 Why?
Hot Temperature
27
2012
198
1.060
 Why?
Radiotherapy Planning, Computer-Assisted
12
2017
253
1.000
 Why?
Antioxidants
2
2020
239
0.900
 Why?
Radiometry
8
2017
123
0.840
 Why?
Neoplasms
19
2016
1251
0.790
 Why?
Tomography, Spiral Computed
5
2017
56
0.720
 Why?
Radiation-Protective Agents
3
2020
72
0.710
 Why?
Abdomen
2
2011
75
0.700
 Why?
Gene Expression Regulation, Neoplastic
12
2012
833
0.650
 Why?
Heart
4
2013
341
0.620
 Why?
Radiotherapy
4
2014
125
0.610
 Why?
Oxygen
3
2012
321
0.610
 Why?
Radiotherapy, Image-Guided
3
2016
23
0.570
 Why?
Pneumonia, Viral
1
2020
169
0.550
 Why?
Radiation Injuries, Experimental
6
2013
80
0.550
 Why?
Coronavirus Infections
1
2020
178
0.540
 Why?
Organ Sparing Treatments
3
2016
56
0.530
 Why?
Pandemics
1
2020
563
0.490
 Why?
Mammary Neoplasms, Experimental
3
2012
121
0.480
 Why?
Radiosurgery
2
2016
123
0.460
 Why?
Animals
47
2021
13124
0.460
 Why?
Cell Survival
22
2012
589
0.450
 Why?
Organs at Risk
3
2016
71
0.440
 Why?
Head and Neck Neoplasms
3
2017
287
0.430
 Why?
Tumor Cells, Cultured
22
2001
457
0.420
 Why?
Radiotherapy Dosage
13
2017
248
0.420
 Why?
Peptides
3
2012
221
0.410
 Why?
HSP70 Heat-Shock Proteins
5
1995
60
0.410
 Why?
Radiation Injuries
3
2013
112
0.410
 Why?
Isoquinolines
5
1996
25
0.400
 Why?
Ultrasonic Therapy
5
2008
34
0.400
 Why?
Galectin 1
1
2012
20
0.390
 Why?
Blood Vessels
1
2012
71
0.380
 Why?
Protein Kinase C
7
1996
71
0.370
 Why?
Molecular Targeted Therapy
1
2012
123
0.370
 Why?
Piperazines
5
1996
119
0.370
 Why?
Brain Neoplasms
2
2012
291
0.370
 Why?
Bone and Bones
2
2011
478
0.350
 Why?
Prostatic Neoplasms
6
2017
384
0.350
 Why?
Myocardium
4
2014
445
0.350
 Why?
Acetylcysteine
2
2010
101
0.340
 Why?
Carcinoma, Squamous Cell
2
2012
326
0.340
 Why?
Fibroblast Growth Factor 2
4
1999
34
0.340
 Why?
Sulfonamides
3
1995
126
0.330
 Why?
Mice
13
2021
5687
0.320
 Why?
Bone Density
1
2011
386
0.320
 Why?
Image Processing, Computer-Assisted
3
2017
243
0.320
 Why?
Cranial Irradiation
2
2009
20
0.320
 Why?
Cerebellar Neoplasms
2
2009
23
0.320
 Why?
Combined Modality Therapy
10
2012
641
0.310
 Why?
Heat-Shock Response
2
2005
26
0.300
 Why?
Medulloblastoma
1
2008
17
0.300
 Why?
Oxygen Consumption
1
2009
190
0.290
 Why?
Humans
59
2021
50503
0.290
 Why?
Sodium Compounds
4
1994
11
0.280
 Why?
Arsenites
4
1994
13
0.280
 Why?
Arsenic
3
1991
22
0.270
 Why?
Whole-Body Irradiation
3
2020
132
0.270
 Why?
Cell Hypoxia
2
2012
82
0.260
 Why?
Radiobiology
1
2005
21
0.250
 Why?
Breast Neoplasms
9
2016
1201
0.250
 Why?
Medicine
1
2005
56
0.240
 Why?
Radiation Dosage
7
2008
162
0.240
 Why?
Dose-Response Relationship, Radiation
8
2012
183
0.240
 Why?
Rats
17
2021
3292
0.240
 Why?
Brain
1
2012
1319
0.220
 Why?
Quercetin
2
1994
15
0.220
 Why?
Brachytherapy
7
1998
46
0.210
 Why?
Signal Transduction
5
2013
1624
0.210
 Why?
Promoter Regions, Genetic
4
2001
465
0.210
 Why?
Tocotrienols
2
2013
37
0.210
 Why?
Radiotherapy, Conformal
2
2016
53
0.210
 Why?
Radiation Tolerance
7
2013
84
0.210
 Why?
Neovascularization, Pathologic
3
2012
155
0.200
 Why?
Mitogen-Activated Protein Kinases
2
2000
155
0.200
 Why?
Paclitaxel
2
2009
84
0.200
 Why?
Transcription Factor AP-1
3
1999
62
0.200
 Why?
Glucose
4
2000
341
0.190
 Why?
Cell Line
12
2005
988
0.190
 Why?
Gene Expression
5
2012
610
0.190
 Why?
Drug Resistance, Multiple
6
2000
24
0.190
 Why?
High-Intensity Focused Ultrasound Ablation
2
2011
14
0.190
 Why?
Cricetinae
14
2021
188
0.190
 Why?
Cell Nucleus
4
1991
182
0.180
 Why?
Cycloheximide
6
1994
35
0.180
 Why?
Lung Neoplasms
3
2017
601
0.180
 Why?
Angiogenesis Inhibitors
2
2012
183
0.170
 Why?
Models, Biological
3
2016
716
0.170
 Why?
Crystallins
2
1996
11
0.160
 Why?
Carcinoma
4
1999
137
0.160
 Why?
Temperature
7
2005
162
0.150
 Why?
Male
21
2021
25907
0.150
 Why?
MicroRNAs
1
2021
344
0.140
 Why?
Tomography, X-Ray Computed
4
2016
1164
0.140
 Why?
Colonic Neoplasms
8
1995
158
0.140
 Why?
Enzyme Inhibitors
3
1996
377
0.140
 Why?
Genes, bcl-2
1
1997
5
0.140
 Why?
Radiation-Sensitizing Agents
2
2010
51
0.140
 Why?
Rectum
4
1998
52
0.140
 Why?
Genes, myc
1
1997
32
0.140
 Why?
RNA, Messenger
7
1999
1089
0.140
 Why?
Esophageal Neoplasms
1
1998
106
0.130
 Why?
Calcitriol
1
1996
39
0.130
 Why?
Kinetics
7
1996
623
0.130
 Why?
Base Sequence
7
1996
639
0.130
 Why?
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
5
1996
7
0.130
 Why?
Time Factors
10
2014
2935
0.130
 Why?
Radiation Protection
2
2016
47
0.130
 Why?
Molecular Sequence Data
7
1996
778
0.130
 Why?
Cell Line, Tumor
4
2012
1398
0.130
 Why?
Mice, Inbred C57BL
2
2011
1808
0.120
 Why?
Fourier Analysis
1
1995
18
0.120
 Why?
DNA-Binding Proteins
3
1994
418
0.120
 Why?
Craniospinal Irradiation
1
2014
9
0.120
 Why?
Radiation Pneumonitis
2
2016
9
0.110
 Why?
Equipment Design
2
2012
289
0.110
 Why?
Harringtonines
1
1993
3
0.110
 Why?
Apoptosis
2
2014
1097
0.110
 Why?
Membrane Proteins
1
1996
332
0.110
 Why?
Phantoms, Imaging
3
2011
122
0.110
 Why?
Carcinoma, Non-Small-Cell Lung
1
2016
154
0.110
 Why?
Pentoxifylline
1
2013
14
0.110
 Why?
Immunohistochemistry
2
2013
957
0.110
 Why?
Antineoplastic Agents, Phytogenic
1
1993
66
0.110
 Why?
Transcription Factors
2
1994
565
0.110
 Why?
Phosphorylation
4
2013
525
0.110
 Why?
Monte Carlo Method
1
2013
85
0.110
 Why?
Oxidative Stress
4
2012
772
0.100
 Why?
Female
25
2021
27081
0.100
 Why?
Kininogens
1
2012
3
0.100
 Why?
Kallikrein-Kinin System
1
2012
3
0.100
 Why?
Ablation Techniques
1
2012
22
0.100
 Why?
Deuterium
1
1992
45
0.100
 Why?
Tumor Burden
2
2010
130
0.100
 Why?
Cisplatin
4
2009
286
0.100
 Why?
Leukemia, Myeloid, Acute
2
2011
181
0.100
 Why?
Computer Simulation
5
2016
279
0.100
 Why?
Bystander Effect
1
2012
25
0.100
 Why?
Carrier Proteins
1
1993
298
0.100
 Why?
Mitogen-Activated Protein Kinase 1
4
2013
50
0.100
 Why?
Oligodeoxyribonucleotides
4
1996
33
0.100
 Why?
Adaptation, Physiological
1
1992
93
0.100
 Why?
Models, Chemical
2
2008
64
0.100
 Why?
Myocarditis
1
2012
46
0.100
 Why?
Adenoviridae
3
2001
48
0.100
 Why?
Acclimatization
1
1991
17
0.100
 Why?
Models, Theoretical
1
2012
170
0.090
 Why?
Organ Specificity
1
2011
109
0.090
 Why?
Genetic Vectors
3
2001
128
0.090
 Why?
Transcription, Genetic
3
1999
361
0.090
 Why?
Cell Proliferation
2
2012
985
0.090
 Why?
Nuclear Proteins
1
1992
238
0.090
 Why?
Neoplasm Proteins
1
1993
320
0.090
 Why?
Transfection
4
2000
356
0.090
 Why?
Mitochondria
1
2014
399
0.090
 Why?
Leukocyte Count
1
2010
69
0.090
 Why?
Radiography
2
2009
485
0.090
 Why?
CHO Cells
5
1992
118
0.090
 Why?
Cytokines
1
1993
606
0.080
 Why?
Drug Resistance, Neoplasm
3
1997
316
0.080
 Why?
Genes, jun
3
1999
21
0.080
 Why?
Middle Aged
9
2021
12611
0.080
 Why?
Genes, fos
3
1999
28
0.080
 Why?
Taxoids
1
2009
37
0.080
 Why?
Carboplatin
1
2009
54
0.080
 Why?
Fluorouracil
1
2009
58
0.080
 Why?
Body Weight
1
2011
517
0.080
 Why?
Disease Progression
1
2012
829
0.080
 Why?
Information Systems
1
1989
27
0.080
 Why?
Nucleoside Deaminases
2
1999
3
0.080
 Why?
Spinal Neoplasms
1
2009
30
0.080
 Why?
Cell Death
3
2005
175
0.080
 Why?
Necrosis
1
2009
174
0.080
 Why?
Follow-Up Studies
3
2009
2242
0.080
 Why?
Thymidine Kinase
2
1999
18
0.080
 Why?
Aged
6
2021
9741
0.080
 Why?
History, 20th Century
1
2009
100
0.080
 Why?
Microscopy, Fluorescence
1
2009
158
0.080
 Why?
Osteogenesis
1
2011
356
0.080
 Why?
Bone Marrow
2
2010
363
0.080
 Why?
Gene Expression Regulation
3
2021
955
0.080
 Why?
Carbon
1
2008
55
0.080
 Why?
Reactive Oxygen Species
1
2010
409
0.070
 Why?
Protein Biosynthesis
1
1990
232
0.070
 Why?
Weight Loss
1
2010
245
0.070
 Why?
Genetic Therapy
2
1999
120
0.070
 Why?
Radiotherapy, Computer-Assisted
1
2007
16
0.070
 Why?
Skull
1
2007
75
0.070
 Why?
Adult
8
2021
13577
0.070
 Why?
Dose-Response Relationship, Drug
4
1995
1372
0.070
 Why?
Spine
1
2007
90
0.070
 Why?
Ovary
6
1990
103
0.070
 Why?
Central Nervous System Neoplasms
1
2007
63
0.070
 Why?
3T3 Cells
3
1996
56
0.070
 Why?
Particle Accelerators
2
2017
51
0.070
 Why?
Antineoplastic Agents
2
1993
1172
0.060
 Why?
Swine
3
2012
408
0.060
 Why?
DNA Damage
4
2012
301
0.060
 Why?
Blotting, Northern
3
1996
110
0.060
 Why?
Rats, Sprague-Dawley
3
2014
1585
0.060
 Why?
DNA Repair
4
1988
188
0.060
 Why?
DNA, Neoplasm
2
1993
143
0.060
 Why?
Antiviral Agents
3
2021
170
0.060
 Why?
Retrospective Studies
3
2012
6263
0.060
 Why?
Aged, 80 and over
3
2021
3226
0.060
 Why?
Treatment Outcome
2
2012
5283
0.060
 Why?
Cytomegalovirus
2
2001
28
0.060
 Why?
Hydrogen-Ion Concentration
3
1994
168
0.060
 Why?
Diathermy
1
1983
1
0.050
 Why?
Recombinant Proteins
3
2000
476
0.050
 Why?
Cricetulus
8
1990
97
0.050
 Why?
Magnetics
1
1983
35
0.050
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2009
1000
0.050
 Why?
X-Rays
4
2016
55
0.050
 Why?
Mitogen-Activated Protein Kinase 3
2
2013
49
0.050
 Why?
JNK Mitogen-Activated Protein Kinases
2
2000
71
0.050
 Why?
Antigens, Differentiation, Myelomonocytic
2
2013
39
0.050
 Why?
Genes, Recessive
1
2002
15
0.050
 Why?
Genetic Heterogeneity
1
2002
17
0.050
 Why?
Flucytosine
2
1999
13
0.050
 Why?
Antimetabolites
2
1999
12
0.050
 Why?
Ganciclovir
2
1999
25
0.050
 Why?
Genetic Markers
1
2002
104
0.050
 Why?
Sensitivity and Specificity
3
2009
859
0.050
 Why?
Microcephaly
1
2002
41
0.050
 Why?
Ultrasonics
1
1982
30
0.050
 Why?
Ferrets
1
2021
6
0.050
 Why?
Antigens, CD
2
2013
222
0.050
 Why?
Leucine
2
1994
117
0.050
 Why?
Genetic Variation
1
2002
207
0.050
 Why?
Glycolysis
1
2021
69
0.050
 Why?
Transgenes
1
2001
52
0.050
 Why?
ROC Curve
1
2021
226
0.050
 Why?
Genes, Reporter
1
2001
88
0.040
 Why?
Luminescent Proteins
1
2001
53
0.040
 Why?
Recombinant Fusion Proteins
2
1999
179
0.040
 Why?
Green Fluorescent Proteins
1
2001
90
0.040
 Why?
Algorithms
2
2016
625
0.040
 Why?
Proto-Oncogene Proteins c-fos
1
1999
61
0.040
 Why?
Proto-Oncogene Proteins c-jun
1
1999
77
0.040
 Why?
Prodrugs
1
1999
31
0.040
 Why?
Rabbits
2
2010
372
0.040
 Why?
Linear Models
2
2016
279
0.040
 Why?
Proteomics
1
2021
314
0.040
 Why?
Clinical Trials as Topic
2
1991
486
0.040
 Why?
Blotting, Western
3
2012
578
0.040
 Why?
Reproducibility of Results
3
2009
1197
0.040
 Why?
Protein Kinase C-alpha
2
2013
10
0.040
 Why?
Rectal Diseases
1
1997
10
0.040
 Why?
Proteins
2
2010
339
0.040
 Why?
Inflammation
1
2021
610
0.030
 Why?
Protein Binding
2
1996
654
0.030
 Why?
Cell Division
2
1996
291
0.030
 Why?
Glioma
3
1993
77
0.030
 Why?
Body Temperature
2
1989
67
0.030
 Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
1996
32
0.030
 Why?
Wound Healing
1
1998
186
0.030
 Why?
Cell Cycle
2
1995
226
0.030
 Why?
Gene Expression Regulation, Enzymologic
1
1998
179
0.030
 Why?
HSP30 Heat-Shock Proteins
1
1996
1
0.030
 Why?
DNA
4
1988
535
0.030
 Why?
Tetradecanoylphorbol Acetate
1
1996
47
0.030
 Why?
Receptors, Calcitriol
1
1996
22
0.030
 Why?
Leukemia, Myeloid
1
1996
44
0.030
 Why?
Isoenzymes
1
1996
168
0.030
 Why?
Cone-Beam Computed Tomography
1
2016
33
0.030
 Why?
Poisson Distribution
1
2016
33
0.030
 Why?
Electrophoresis, Polyacrylamide Gel
2
1996
98
0.030
 Why?
Quality Assurance, Health Care
3
1991
150
0.030
 Why?
Flow Cytometry
2
1996
474
0.030
 Why?
Probability
1
2016
164
0.030
 Why?
Adolescent
4
2009
6443
0.030
 Why?
Hypoglycemia
1
1996
55
0.030
 Why?
G2 Phase
1
1995
13
0.030
 Why?
Multiple Myeloma
1
2010
2998
0.030
 Why?
Fibrosarcoma
2
2011
12
0.030
 Why?
Radio Waves
1
1995
7
0.030
 Why?
Neoplasms, Experimental
2
2009
110
0.030
 Why?
Thermodynamics
1
1995
33
0.030
 Why?
Mathematics
1
1995
44
0.030
 Why?
Radiation, Ionizing
1
1995
100
0.030
 Why?
Mitosis
1
1995
88
0.030
 Why?
Dimethyl Sulfoxide
1
1994
13
0.030
 Why?
Mitochondrial Membrane Transport Proteins
1
2014
18
0.030
 Why?
Membrane Potential, Mitochondrial
1
2014
36
0.030
 Why?
Gliosarcoma
1
1994
5
0.030
 Why?
Cell Respiration
1
2014
41
0.030
 Why?
HSC70 Heat-Shock Proteins
1
1993
7
0.030
 Why?
Enzyme Activation
3
2000
268
0.030
 Why?
bcl-2-Associated X Protein
1
2014
57
0.030
 Why?
Cyclic AMP-Dependent Protein Kinases
1
1994
51
0.030
 Why?
Child, Preschool
3
2009
3942
0.030
 Why?
Protein Conformation
1
2014
162
0.030
 Why?
Software
1
2016
276
0.030
 Why?
Cell Count
1
2013
150
0.030
 Why?
Mast Cells
1
2013
54
0.030
 Why?
Cells, Cultured
4
1991
1571
0.030
 Why?
Cell Differentiation
1
1996
640
0.030
 Why?
Proto-Oncogene Proteins c-bcl-2
1
2014
128
0.030
 Why?
Drug Interactions
1
2013
206
0.030
 Why?
Skin Temperature
1
2012
15
0.030
 Why?
Multigene Family
1
1992
54
0.030
 Why?
Mitochondrial Swelling
1
2012
4
0.030
 Why?
Rats, Inbred BN
1
2012
13
0.030
 Why?
Proto-Oncogene Proteins c-akt
1
2013
156
0.030
 Why?
Receptor, Bradykinin B2
1
2012
7
0.030
 Why?
Models, Animal
1
2013
227
0.030
 Why?
DNA Probes
1
1992
29
0.030
 Why?
Film Dosimetry
1
2012
15
0.020
 Why?
Up-Regulation
1
2014
446
0.020
 Why?
Administration, Oral
1
2013
434
0.020
 Why?
MAP Kinase Signaling System
1
2012
117
0.020
 Why?
Cell Fractionation
1
1991
11
0.020
 Why?
Neck
1
2012
99
0.020
 Why?
Burns
2
2012
165
0.020
 Why?
Endothelial Cells
1
2013
258
0.020
 Why?
Computer-Aided Design
1
2011
22
0.020
 Why?
Equipment Failure Analysis
1
2011
45
0.020
 Why?
Evaluation Studies as Topic
2
1988
107
0.020
 Why?
Partial Pressure
1
2011
14
0.020
 Why?
Heart Ventricles
1
2013
265
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2012
572
0.020
 Why?
Protein Synthesis Inhibitors
1
1990
17
0.020
 Why?
Bone Transplantation
1
2010
45
0.020
 Why?
Child
3
2009
6906
0.020
 Why?
Cell Transformation, Neoplastic
1
2011
181
0.020
 Why?
Protein Transport
1
2010
181
0.020
 Why?
Feasibility Studies
1
2011
390
0.020
 Why?
Proliferating Cell Nuclear Antigen
1
2009
68
0.020
 Why?
Filing
1
1989
1
0.020
 Why?
DNA, Single-Stranded
3
1979
89
0.020
 Why?
Mammary Glands, Animal
1
2009
69
0.020
 Why?
Cytosine Deaminase
2
1999
7
0.020
 Why?
Metaphase
1
1968
45
0.020
 Why?
Chromosomes
1
1968
31
0.020
 Why?
Metals
1
2008
35
0.020
 Why?
Acute Disease
1
2009
373
0.020
 Why?
Glutathione
2
2000
299
0.020
 Why?
Lung
1
2011
504
0.020
 Why?
Survival Rate
1
2009
909
0.020
 Why?
Skin
1
2009
388
0.020
 Why?
Kidney
1
2011
696
0.020
 Why?
Rats, Wistar
2
1997
224
0.020
 Why?
Severity of Illness Index
1
2009
978
0.020
 Why?
Liver
1
2011
1132
0.020
 Why?
Electrodes
1
1984
35
0.010
 Why?
Consanguinity
1
2002
17
0.010
 Why?
Microsatellite Repeats
1
2002
37
0.010
 Why?
Medical Laboratory Science
1
1982
2
0.010
 Why?
Cystamine
1
1982
2
0.010
 Why?
Cysteamine
1
1982
7
0.010
 Why?
Gases
1
1982
9
0.010
 Why?
Methods
1
1981
55
0.010
 Why?
Thoracic Neoplasms
1
1981
13
0.010
 Why?
Abdominal Neoplasms
1
1981
15
0.010
 Why?
Pelvic Neoplasms
1
1981
14
0.010
 Why?
Cell Adhesion
1
1982
157
0.010
 Why?
Intellectual Disability
1
2002
127
0.010
 Why?
Cytarabine
1
1981
37
0.010
 Why?
Clinical Protocols
2
1991
110
0.010
 Why?
Mitomycins
1
1980
2
0.010
 Why?
Dipeptides
1
2000
22
0.010
 Why?
Cysteine
1
2000
50
0.010
 Why?
Phenotype
1
2002
739
0.010
 Why?
Bleomycin
1
1979
34
0.010
 Why?
Young Adult
1
2009
4102
0.010
 Why?
Antimetabolites, Antineoplastic
1
1999
35
0.010
 Why?
Gene Expression Regulation, Viral
1
1999
47
0.010
 Why?
Proto-Oncogene Proteins c-myc
1
1999
50
0.010
 Why?
Herpesvirus 1, Human
1
1998
15
0.010
 Why?
Doxorubicin
1
2000
236
0.010
 Why?
Glutathione Disulfide
1
1998
40
0.010
 Why?
Gene Transfer Techniques
1
1998
41
0.010
 Why?
Iridium Radioisotopes
1
1997
3
0.010
 Why?
Glutamic Acid
1
1998
113
0.010
 Why?
S Phase
1
1996
18
0.010
 Why?
Escherichia coli
1
1998
190
0.010
 Why?
Glutamine
1
1998
175
0.010
 Why?
DNA, Complementary
1
1996
133
0.010
 Why?
Cytoplasm
1
1996
89
0.010
 Why?
Adenocarcinoma
1
1980
397
0.010
 Why?
Intestinal Obstruction
1
1996
36
0.010
 Why?
Diarrhea
1
1996
90
0.010
 Why?
Plasmids
1
1996
164
0.010
 Why?
Infant, Newborn
1
2002
2749
0.010
 Why?
Sodium Salicylate
1
1994
4
0.010
 Why?
Cadmium Chloride
1
1994
3
0.010
 Why?
Stimulation, Chemical
1
1994
30
0.010
 Why?
Physical Stimulation
1
1994
35
0.010
 Why?
Electrons
1
1974
19
0.010
 Why?
Adaptation, Biological
1
1994
10
0.010
 Why?
Cadmium
1
1994
21
0.010
 Why?
Regulatory Sequences, Nucleic Acid
1
1994
40
0.010
 Why?
Chlorides
1
1994
49
0.010
 Why?
Infant
1
2002
3628
0.010
 Why?
Stress, Physiological
1
1994
171
0.010
 Why?
Disease Models, Animal
1
1997
1436
0.010
 Why?
Equipment Safety
1
1991
12
0.010
 Why?
Fibroblasts
1
1993
336
0.010
 Why?
Documentation
1
1991
33
0.010
 Why?
Histidinol
1
1990
1
0.010
 Why?
Puromycin
1
1990
3
0.010
 Why?
Electromagnetic Phenomena
1
1988
4
0.000
 Why?
Drug Synergism
1
1981
151
0.000
 Why?
Cross-Linking Reagents
1
1980
41
0.000
 Why?
Remission, Spontaneous
1
1979
24
0.000
 Why?
Creatine Kinase
1
1979
29
0.000
 Why?
L-Lactate Dehydrogenase
1
1979
60
0.000
 Why?
Tachycardia
1
1979
28
0.000
 Why?
Etoposide
1
1979
77
0.000
 Why?
Drug Therapy, Combination
1
1980
384
0.000
 Why?
Peripheral Nervous System Diseases
1
1979
58
0.000
 Why?
Neoplasm Metastasis
1
1979
232
0.000
 Why?
Melphalan
1
1979
178
0.000
 Why?
Electroencephalography
1
1979
304
0.000
 Why?
Melanoma
1
1979
280
0.000
 Why?
Relative Biological Effectiveness
1
1974
8
0.000
 Why?
Centrifugation, Density Gradient
1
1974
18
0.000
 Why?
Gamma Rays
1
1974
47
0.000
 Why?
Corry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (422) concept(s)
_
Co-Authors Expand Description
See all (9) people
_
Similar People Expand Description
See all (35) people
_
Same Department Expand Description
Search Department